Dr. Adam Richard Zybulewski, MD

Dr. Zybulewski practices at Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida.

Dr. Zybulewski's NPI, 1023436235, was assigned on April 3, 2014. Dr. Zybulewski graduated from Rutgers Robert Wood Johnson Medical School in 2013. Dr. Zybulewski holds Florida license ME141477.

Dr. Zybulewski's primary practice is Mount Sinai Medical Center, at 4300 Alton Rd, Miami Beach, FL 33140 in Miami-Dade County. The practice phone is (305) 674-2121.

Dr. Zybulewski's primary practice is Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida. The medical group on file is Mount Sinai Vascular Institute. Dmand AI also links Dr. Zybulewski to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zybulewski practices. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Zybulewski's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Zybulewski is board certified in interventional radiology and diagnostic radiology by the American Board of Radiology. Dmand AI has Dr. Zybulewski's licenses on file in 2 states: Florida and New Jersey.

CMS data shows 335 Medicare services from Dr. Zybulewski across 11 procedure codes in 2024, for 188 Medicare patients. Medicare paid $25,553 for them.

CMS counts 188 Medicare patients who saw Dr. Zybulewski in 2024. The largest group is 75 to 84, with 77 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 3.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zybulewski's median patient age at 71, with 41% women.

In 2024, Dr. Zybulewski wrote 35 Medicare Part D claims for 20 patients. 97% of them were for generic drugs. CMS names the drug for 27 of them, across 2 drugs with 11 or more claims each, at $112 in total drug cost. In 2022, CMS named 20 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Zybulewski for performance year 2024, reported as part of a group. Dr. Zybulewski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zybulewski as offering telehealth.

Dmand AI links 9 papers to Dr. Zybulewski, published from 2016 to 2023. 2017 was the busiest year, with 2. The most frequent topics are Iliac Vein. Dr. Zybulewski's most frequent co-authors are Suman Annambhotla, MD, Matthew C. Bunte, MD and Aaron M. Fischman, MD.

CMS Open Payments shows 190 general payments to Dr. Zybulewski from 28 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 87% of the total. Boston Scientific Corporation paid the most, $4,043.

Dr. Zybulewski graduated from Rutgers Robert Wood Johnson Medical School in 2013.

Dr. Zybulewski is in network with 5 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.